Sophomer s.r.o.
Our team
Martin Burkhard
Expert in IVD development
Founder & Managing Director – CEO Operations & Development
Jan Plicka
Leading expert in IVD development
Founder and Inventor
& Managing director
– R&D
Tereza Vodičková
Head of Laboratory
Planning and organisation of laboratory activities
Jiří Moos
i&i Prague CEO
Tomáš Etrych
Scientists from the Institute of Macromolecular Chemistry (IMC)
Libor Kostka
Scientists from the Institute of Macromolecular Chemistry (IMC)
Vladimír Šubr
Scientists from the Institute of Macromolecular Chemistry (IMC)
Founder and Inventor
& Managing director
Business Development
Founders and Inventors & Sophomer′s Partner Lab Design and synthesis of new polymers in partnering IMC lab
Jiří Moos
i&i Prague CEO
Founder and Inventor
& Managing director
Business Development
Tomáš Etrych
Scientists from the Institute of Macromolecular Chemistry (IMC)
Founder and Inventor & Sophomer′s Partner Lab Design and synthesis of new polymers in partnering IMC lab
Libor Kostka
Scientists from the Institute of Macromolecular Chemistry (IMC)
Founder and Inventor & Sophomer′s Partner Lab Design and synthesis of new polymers in partnering IMC lab
Vladimír Šubr
Scientists from the Institute of Macromolecular Chemistry (IMC)
Founder and Inventor & Sophomer′s Partner Lab Design and synthesis of new polymers in partnering IMC lab
Partners
Institute of Macromolecular Chemistry of the CAS (IMC) 
The Institute of Macromolecular Chemistry of the CAS, v. v. i. (IMC) is the largest research institution in the field of polymer and polymer materials research in the Czech Republic. In this field, IMC belongs to the most important academic research centers in the world. IMC has a knowledge potential of more than 120 scientists in the key fields of macromolecular chemistry, physical chemistry and polymer physics, as well as in related fields such as biochemistry or biomedical or materials engineering. Although the institute is primarily focused on basic research, it also works closely with the industry, as evidenced by a number of applied basic research results.
Institute of Molecular Genetics of the CAS (IMG) 
The principal mission of IMG is experimental biology research. The research is focused on the molecular bases of serious diseases (e.g., cancer, leukemia, AIDS), biology of normal and transformed cells, immune mechanisms involved in the defense of the organism, DNA repair mechanisms, and cellular senescence. The strength of the Institute is the state-of-the-art equipment, which is either operated within the core facilities, service research groups, or in the large national research infrastructures. Services and sophisticated instruments are not utilized by the scientists from IMG only, but can also be used by researchers from other institutions. IMG thus significantly supports the scientific community in the Czech Republic and abroad.
i&i Biotech Fund 
i&i Bio is a Luxembourg-based venture capital company that invests in innovative European Life Sciences companies focused on drug discoveries, medical devices, diagnostics, and digital health. The Fund was created thanks to the cooperation of the biotech incubator i&i Prague and the European Investment Fund (see below). With over €47M under management, i&i Bio plans to invest in about 20 early-stage companies. i&i Bio is led by an experienced team of professionals with backgrounds in private equity, healthcare and venture capital supporting entrepreneurs on their journey to global success. Thanks to close cooperation with the fund’s main sponsor, the biotech academic incubator i&i Prague, i&i Bio is supporting and advancing transformative Central European technology companies.
Biovendor 
At BioVendor Group, we believe that every treatment starts with a reliable diagnosis. That’s why we look for innovative ways to provide credible laboratory results to doctors and patients around the world. We are an international group of biotechnology companies focused on the development, manufacture and distribution of IVD products and technologies for laboratory automation.